| 来源类型 | Working Paper |
| 规范类型 | 论文 |
| Medicine Registration and Medicine Quality: A Preliminary Analysis of Key Cities in Emerging Markets | |
| Roger Bate; Lorraine Mooney; Kimberly Hess | |
| 发表日期 | 2010-12-13 |
| 出版年 | 2010 |
| 语种 | 英语 |
| 摘要 | Background: The medicine registration process is not just a matter of formality but involves assessment of medicine quality and stability. It is perhaps the most important as well as the simplest aspect of medicine regulation. This study attempts to ascertain whether registered medicines perform better in simple quality tests than those that are either not registered or not known to be registered. Methods: Over the past 30 months, 2065 essential medicines (for treatment of malaria, tuberculosis, and bacterial infections) were procured by covert shoppers from 11 African cities and from eight cities in a variety of middle-income nations. All samples were assessed using the Global Pharma Health Fund e.V. Minilab® protocol, which includes visual inspection, semiquantitative thin-layer chromatography, and disintegration testing, to identify whether they were substandard, degraded, or counterfeit. Results: Where medicine registration data were available, 1940 medicines were identified, of which 1589 were registered and 351 were either unregistered or not known to be registered. The failure rate among registered medicines was 5% (79/1589) and 37.3% (131/351) amongst medicines that were either unregistered or not known to be registered. African cities had fewer medicines registered (71%, or 488/687) than Indian cities (86.9%, or 610/702) or other middle-income cities (89.1%, or 491/551). Samples from African cities performed far worse in quality tests (18.6% failed, or 128/687) than either samples from Indian cities (8.7% failed, or 61/702) or other middle-income cities (3.8% failed, or 21/551). There was also a notable disparity in failure rates by medicine type; 14.2% (101/710) of antimalarials failed testing, 10.1% (70/693) of antibiotics failed, and 7.3% (39/537) of antimycobacterials failed. Conclusion: The results strongly indicate that medicine registration is an important component of better-quality medicines. Registered medicines performed better than unregistered medicines, and the result was strongly statistically significant. View the full report as an Adobe Acrobat PDF. Roger Bate is the Legatum Fellow in Global Prosperity at AEI. Photo Credit: iStockphoto/Kenneth C. Zirkel |
| 主题 | Health Care |
| 标签 | Cities ; markets ; medicine ; Pharmaceuticals |
| URL | https://www.aei.org/research-products/working-paper/medicine-registration-and-medicine-quality-a-preliminary-analysis-of-key-cities-in-emerging-markets/ |
| 来源智库 | American Enterprise Institute (United States) |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/207092 |
| 推荐引用方式 GB/T 7714 | Roger Bate,Lorraine Mooney,Kimberly Hess. Medicine Registration and Medicine Quality: A Preliminary Analysis of Key Cities in Emerging Markets. 2010. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| medicine-registratio（110KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
